InChI=1S/C27H44O2/c1-17(2)7-6-8-18(3)21-9-10-22-25-23(12-14-27(21,22)5)26(4)13-11-20(28)15-19(26)16-24(25)29/h16-18,20-23,25,28H,6-15H2,1-5H3/t18-,20+,21-,22+,23+,25+,26+,27-/m1/s1 |
YIKKMWSQVKJCOP-ABXCMAEBSA-N |
[H][C@@]1(CC[C@@]2([H])[C@]3([H])C(=O)C=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C |
|
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
|
|
View more via ChEBI Ontology
3β-hydroxycholest-5-en-7-one
|
(3-beta)-3-Hydroxycholest-5-en-7-one
|
ChemIDplus
|
(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-7-one
|
SUBMITTER
|
3-beta-Hydroxycholest-5-en-7-one
|
ChemIDplus
|
7-oxocholesterol
|
UniProt
|
7-oxocholesterol
|
SUBMITTER
|
2169084
|
Reaxys Registry Number
|
Reaxys
|
566-28-9
|
CAS Registry Number
|
ChemIDplus
|
17846428
|
PubMed citation
|
Europe PMC
|
18469840
|
PubMed citation
|
Europe PMC
|
18495460
|
PubMed citation
|
Europe PMC
|
18603819
|
PubMed citation
|
Europe PMC
|
18936140
|
PubMed citation
|
Europe PMC
|
19351882
|
PubMed citation
|
Europe PMC
|
19429117
|
PubMed citation
|
Europe PMC
|
19464253
|
PubMed citation
|
Europe PMC
|
19834037
|
PubMed citation
|
Europe PMC
|
19880645
|
PubMed citation
|
Europe PMC
|
20424663
|
PubMed citation
|
Europe PMC
|
20463934
|
PubMed citation
|
Europe PMC
|
20466046
|
PubMed citation
|
Europe PMC
|
20471966
|
PubMed citation
|
Europe PMC
|
20554621
|
PubMed citation
|
Europe PMC
|
20698354
|
PubMed citation
|
Europe PMC
|
21035514
|
PubMed citation
|
Europe PMC
|
|